Advanced Health Limited
(Incorporated in the Republic of South Africa)
(Registration number: 2013/059246/06)
Share code: AVL ISIN: ZAE000189049
(“Advanced Health” or “the Company”)


RESULTS OF SCHEME MEETING


Shareholders are referred to the announcement and the circular issued to Advanced Health shareholders on
Wednesday, 26 July 2022 (the “Scheme Circular”) relating to the offer by Eenhede Konsultante Eiendoms Beperk
to acquire all of the issued shares of Advanced Health, other than the Advanced Health shares held by VC Family
Trust, Carl Grillenberger Family Trust and Pres Medical Witbank Proprietary Limited, for an offer consideration of
80 cents per Advanced Health share, to be effected by way of a scheme of arrangement in terms of 114(1)(c) of
the Companies Act, 71 of 2008 (the “Companies Act”) (read with section 115 of the Companies Act)) between
Advanced Health and its shareholders (the “Scheme”). Terms defined in the Scheme Circular will, where used in
this announcement, bear the same meaning as ascribed to them in the Scheme Circular.

Shareholders are advised that at the Scheme Meeting held on Friday, 25 August 2023, all resolutions required to
be passed by Advanced Health Shareholders in order to approve the Scheme, were passed by the requisite majority
of Shareholders.

Details of the results of voting at the Scheme Meeting are as follows:

-       Total number of Advanced Health Shares in issue as at the date of the Scheme Meeting: 498 784 580
-       Total number of Advanced Health Shares that could have been voted at the Scheme Meeting: 144 017 094
-       Total number of Advanced Health Shares present or represented at the Scheme Meeting: 109 291 960, being
        75.89% of the total number of Advanced Health Shares that could have been voted at the Scheme Meeting.

Special resolution number 1: Approval of the Scheme Resolution in accordance with of section 115(2)(a) of the
Companies Act

    Shares voted *            For                         Against                       Abstentions ^
    109 188 860               109 041 361                 147 499                       103 100
    75.89%                    99.86%                      0.14%                         0.02%

Special resolution number 1: Revocation of Scheme Resolution in accordance with section 164(9) of the Companies
Act

    Shares voted *            For                         Against                       Abstentions ^
    109 188 860               109 041 361                 147 499                       103 100
    75.89%                    99.86%                      0.14%                         0.02%

*       shares voted (excluding abstentions) in relation to the total number of Shares in issue (excluding Shares held
        by the Offeror and the Excluded Shareholders)
^       in relation to total Shares is issue

A further announcement regarding the fulfilment and/or waiver of the outstanding conditions precedent to the
Scheme will be released in due course.

The Independent Board accepts responsibility for the information contained in this announcement, confirms that to
the best of its knowledge and belief, the information contained in this announcement is true and correct and that
this announcement does not omit anything likely to affect the importance of the information contained in it.

Pretoria

25 August 2023


Corporate Advisor and Transaction Sponsor